InflaRx (IFRX) Other Operating Expenses (2016 - 2026)

InflaRx has disclosed Other Operating Expenses across 11 years of filings, most recently posting -$126524.8 for Q1 2026.

• Other Operating Expenses for Q1 2026 came in at -$126524.8, up 91.75% year-over-year; the trailing twelve-month figure through Mar 2026 was -$13.0 billion (up 19.84% YoY), and the FY2022 annual result was -$53456.5 billion, changed N/A from the prior year.
• Other Operating Expenses came in at -$126524.8 for Q1 2026 at InflaRx, up from -$1.4 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $19685.6 billion in Q1 2023 to a low of -$53456.5 billion in Q4 2022.
• The 5-year median for Other Operating Expenses is -$1.7 million (2023), against an average of -$5370.6 billion.
• Across the five-year window, Other Operating Expenses plunged 5.41313159135233e+16% in 2022 and jumped 99.95% in 2024, its largest moves.
• InflaRx's Other Operating Expenses stood at -$53456.5 billion in 2022, then soared by 100.0% to -$1.7 million in 2023, then dropped by 10.26% to -$1.9 million in 2024, then gained by 27.1% to -$1.4 million in 2025, then jumped by 90.75% to -$126524.8 in 2026.
• The last three Other Operating Expenses figures came in at -$126524.8 (Q1 2026), -$1.4 million (Q3 2025), and -$13.0 billion (Q2 2025), per Business Quant data.